A new, two-dose Covid vaccine showed 100% efficacy against severe disease, and may be an effective booster for other shots, its makers said.

Wednesday, February 23, 2022 10:35 AM EST

The two Europe-based pharmaceutical companies that made the vaccine, Sanofi and GSK, said they intend to submit it for authorization to regulatory authorities in the United States and Europe.

Read the latest